Business
FDA bans widely used Red No 3 Food Dye in US
By 
The Food and Drug Administration (FDA) announced on Wednesday that it is banning the use of Red No. 3, a synthetic dye responsible for the vibrant cherry red color in foods and beverages, citing its association with cancer in animal studies:
The dye is still used in thousands of foods, including candy, cereals, cherries in fruit cocktails and strawberry-flavored milkshakes, according to the Center for Science in the Public Interest, a food safety advocacy group that petitioned the agency in 2022 to end its use.
Food manufacturers will have until Jan. 15, 2027 to reformulate their products. Companies that make ingested drugs, such as dietary supplements, will get an additional year.
 |
This ban was LONG overdue. Unfortunately, the other synthetic food dyes that have also been linked to serious deleterious health effects still remain on the market. A few months ago, I summarized the harm linked to synthetic food dyes — outdated FDA standards expose Americans to toxic food dyes linked to cancer, neurobehavioral issues, and other health risks, demanding urgent regulatory action:
Synthetic Food Dyes: A Half-Century of Harm |
||||||
|
||||||
 |
||||||
| by Nicolas Hulscher, MPH | ||||||
|
|
Batada et al found that nearly half (43.2%) of grocery store products contained artificial food colorings (AFCs), with Red 40 (29.8%), Blue 1 (24.2%), Yellow 5 (20.5%), and Yellow 6 (19.5%) being the most common. Candies (96.3%), fruit-flavored snacks (94%), and drink mixes/powders (89.7%) had the highest prevalence of AFCs, while produce contained none.
Oliveira et al summarized the deleterious health effects linked to synthetic food colorings in children: neurobehavioral disorders, allergic reactions, carcinogenic and mutagenic potential, gastrointestinal and respiratory issues, toxicity, developmental and growth delays, and behavioral changes.
Sultana et al illustrated the specific health hazards associated with particular synthetic food dyes:
Miller et al conducted a systematic review of the potential neurobehavioral impacts (activity and attention) of food dye consumption. They included 27 clinical trials of children exposed to synthetic food dyes and found that 16 of 25 challenge studies (64%) demonstrated evidence of a positive association, with 13 studies (52%) reporting statistically significant findings. The authors concluded, “Current evidence from studies in humans, largely from controlled exposure studies in children, supports a relationship between food dye exposure and adverse behavioral outcomes in children, both with and without pre-existing behavioral disorders.” They also noted that:
“Animal toxicology studies were used by FDA as the basis for regulatory risk assessments of food dyes [25]. All current dye registrations were made between 1969 and 1986 based on studies performed 35 to 50 years ago. These studies were not designed to assess neurobehavioral endpoints. Dye registration was accompanied by derivation of an “acceptable daily intake” (ADI) based on these studies. FDA ADIs have not been updated since original dye registration, although there have been several reviews of specific effects since then, the latest in 2011.”
Synthetic food dyes, widely prevalent in U.S. products and lacking nutritional value, rely on outdated FDA approvals despite evidence of widespread toxicity, carcinogenicity, and adverse neurobehavioral effects, strongly warranting urgent regulatory action to protect public health.
While the FDA has finally made a decision that will benefit public health, they are still allowing the dangerous COVID-19 genetic injections to be administered to all individuals aged 6 months and older despite far exceeding criteria for a Class I recall. The immediate removal of unsafe and ineffective gene therapy injections should be the first priority before anything other product bans.
Nicolas Hulscher, MPH
Epidemiologist and Foundation Administrator, McCullough Foundation
Please consider following the McCullough Foundation and Nicolas Hulscher on X (formerly Twitter) for further content.
From LifeSiteNews
The Center for Innovative Public Health Research’s website suggests teenage girls make their ‘own decisions’ about sex and not let their parents know if they don’t want to.
For almost a decade, the U.S. government funded a group that actively works to teach kids how to use sex toys and then keep them hidden from their parents to the tune of $22 million.
According to investigative reporter Hannah Grossman at the Manhattan Institute, The Center for Innovative Public Health Research (CIPHR) has been educating minors about sex toys with public funds.
Records show that the millions given to the group since 2016, according to its website, go toward “health education programs” that “promote positive human development.”
However, the actual contents of the programs, as can be seen from comments from CIPHR CEO Michele Ybarra, seem to suggest that its idea of “human” development is skewed toward radical sex education doctrine.
In 2017, CIPHR launched Girl2Girl, which is funded by federal money to promote “sex-ed program just for teen girls who are into girls.” Its website lets users, who are girls between ages 14 and 16, sign up for “daily text messages … about things like sex with girls and boys.”
The actual content of some of the messages is very concerning. Its website notes that some of the texts talk about “lube and sex toys” as well as “the different types of sex and ways to increase pleasure.”
The website actively calls upon teenage girls to make their “own decisions” and not let their parents know if they don’t want to.
Grossman shared a video clip on X of Ybarra explaining how they educate minors about the use of “sex toys” and dealing with their parents if they are found out.
The clip, from a 2022 Brown University webinar, shows Ybarra telling researchers how to prepare “young person(s)” for her research.
She said if they are doing “focus groups,” she will ask them, “Okay, so what happens if somebody comes into the room and sees words like penis and sex toys on your screen — on your computer screen or on your phone? What if it’s your mom?’”
In 2023, CIPHR launched Transcendent Health, which is a sex-education program for minors who are gender confused. This initiative received $1.3 million of federal grant money that expired last month.
Grossman observed that the federal government “should not fund programs that send sexually explicit messages to minors and encourage them to conceal these communications from parents.”
She noted that in order to protect children and “prevent further harm,” U.S. President Donald Trump’s Department of Health and Human Services “should immediately cancel CIPHR’s active contract and deny its future grant applications.”
“By doing so, the Trump administration can send a clear message: Taxpayers will no longer foot the bill for perverted ‘research’ projects,” she noted.
The Trump administration has thus far, through the Department of Government Efficiency (DOGE), exposed billions in government waste and fraud. Many such uses of taxpayer dollars are currently under review by the administration, including pro-abortion and pro-censorship activity through USAID, “Diversity, Equity, and Inclusion and neo-Marxist class warfare propaganda” through the National Science Foundation, and billions to left-wing “green energy” nonprofits through the Environmental Protection Agency.
Business
Canadian Police Raid Sophisticated Vancouver Fentanyl Labs, But Insist Millions of Pills Not Destined for U.S.
Sam Cooper
Mounties say labs outfitted with high-grade chemistry equipment and a trained chemist reveal transnational crime groups are advancing in technical sophistication and drug production capacity
Amid a growing trade war between Washington and Beijing, Canada—targeted alongside Mexico and China for special tariffs related to Chinese fentanyl supply chains—has dismantled a sophisticated network of fentanyl labs across British Columbia and arrested an academic lab chemist, the RCMP said Thursday.
At a press conference in Vancouver, senior investigators stood behind seized lab equipment and fentanyl supplies, telling reporters the operation had prevented millions of potentially lethal pills from reaching the streets.
“This interdiction has prevented several million potentially lethal doses of fentanyl from being produced and distributed across Canada,” said Cpl. Arash Seyed. But the presence of commercial-grade laboratory equipment at each of the sites—paired with the arrest of a suspect believed to have formal training in chemistry—signals an evolution in the capabilities of organized crime networks, with “progressively enhanced scientific and technical expertise among transnational organized crime groups involved in the production and distribution of illicit drugs,” Seyed added.
This investigation is ongoing, while the seized drugs, precursor chemicals, and other evidence continue to be processed, police said.
Recent Canadian data confirms the country has become an exporter of fentanyl, and experts identify British Columbia as the epicenter of clandestine labs supplied by Chinese precursors and linked to Mexican cartel distributors upstream.
In a statement that appears politically responsive to the evolving Trump trade threats, Assistant Commissioner David Teboul said, “There continues to be no evidence, in this case and others, that these labs are producing fentanyl for exportation into the United States.”
In late March, during coordinated raids across the suburban municipalities of Pitt Meadows, Mission, Aldergrove, Langley, and Richmond, investigators took down three clandestine fentanyl production sites.
The labs were described by the RCMP as “equipped with specialized chemical processing equipment often found in academic and professional research facilities.” Photos released by authorities show stainless steel reaction vessels, industrial filters, and what appear to be commercial-scale tablet presses and drying trays—pointing to mass production capabilities.
The takedown comes as Canada finds itself in the crosshairs of intensifying geopolitical tension.
Fentanyl remains the leading cause of drug-related deaths in Canada, with toxic supply chains increasingly linked to hybrid transnational networks involving Chinese chemical brokers and domestic Canadian producers.
RCMP said the sprawling B.C. lab probe was launched in the summer of 2023, with teams initiating an investigation into the importation of unregulated chemicals and commercial laboratory equipment that could be used for synthesizing illicit drugs including fentanyl, MDMA, and GHB.
The Bureau is a reader-supported publication.
To receive new posts and support my work, consider becoming a free or paid subscriber.
Invite your friends and earn rewards
Poilievre To Create ‘Canada First’ National Energy Corridor
Trump Takes More Action To Get Government Out Of LNG’s Way
Mainstream Media Election Coverage: If the Election Was a NHL Game, the Ice Would be Constantly Tilted Up and to the Left
Selective reporting on measles outbreaks is a globalist smear campaign against Trump administration.
FREE MARINE LE PEN!’: Trump defends French populist against ‘lawfare’ charges
Jury verdict against oil industry worries critics, could drive up energy costs
The book the carbon taxers don’t want you to read
-
2025 Federal Election1 day agoRCMP memo warns of Chinese interference on Canadian university campuses to affect election
-
2025 Federal Election2 days agoFifty Shades of Mark Carney
-
2025 Federal Election19 hours agoResearchers Link China’s Intelligence and Elite Influence Arms to B.C. Government, Liberal Party, and Trudeau-Appointed Senator
-
2025 Federal Election2 days agoCommunist China helped boost Mark Carney’s image on social media, election watchdog reports
-
2025 Federal Election2 days agoConservative Party urges investigation into Carney plan to spend $1 billion on heat pumps
-
MAiD2 days agoDisability rights panel calls out Canada, US states pushing euthanasia on sick patients
-
Justice2 days agoCanadian government sued for forcing women to share spaces with ‘transgender’ male prisoners
-
Alberta2 days agoAlberta takes big step towards shorter wait times and higher quality health care